-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : WELLS FARGO CUTS TARGET PRICE TO $316 FROM $377

Reuters·07/31/2026 10:34:09

Please log in to view news